LabConnect Uses Custom Approach to Enhance Clinical Data Mining
LabConnect, LLC has released its BioVisualization software platform
LabConnect, LLC., a provider of central laboratory services to the biopharmaceutical industry, has released its BioVisualization software platform, which will enable the visualization of data trends from clinical trials. BioVisualization is a proprietary and customizable software platform that queries clinical sample database(s) in real time to analyze and provide visual interpretations of a project’s data. This platform is designed to quickly generate customizable figures, which can be downloaded and shared among colleagues and incorporated into reporting documents.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025